Clinical Trials Browser

Phase 2 × Leukemia, B-Cell × Lenalidomide × Clear all

NCT00751296 2016-06-16

Rev-CLL

Phase 2 Terminated

27 enrolled 7 charts

LymphoidOther hematologic neoplasm

Leukemia, B-Cell

NCT01127542 2011-12-05

RESPeCT

Phase 2 Terminated

LymphoidOther hematologic neoplasm

Leukemia, B-Cell